Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

VolumeIssuePage

Issues

Vascular Dysfunction in Hyperhomocyst(e)inemia. Implications for Atherothrombotic Disease

Olaf Stanger / Martin Weger / Wilfried Renner / Ricarda Konetschny

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 39, Issue 8, Pages 725–733, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2001.121, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Elevated plasma homocyst(e)ine is currently accepted as a major, independent risk factor for atherosclerosis and venous thrombosis. Even moderate hyperhomocyst( e)inemia is prospectively associated with increased risk of mortality in patients with cardiovascular disease. However, the underlying mechanisms resulting in vascular damage are not clearly defined.

The endothelium exerts fundamental control on the vascular tone, coagulation and fibrinolysis. Injury to the endothelium followed by dysfunction is an early key event preceding manifestation of vessel pathology. Acute and chronic exposure of endothelium to homocyst(e)ine induces impairment of endothelial function associated with altered homeostasis and morphologic changes of the vessel wall.

Investigations of the role of homocyst(e)ine in the endothelium-dependent function in healthy subjects and cardiovascular patients have recently added important clinical insight with implications for the treatment of cardiovascular disease. Importantly, the damaging effects of hyperhomocyst(e)inemia on endothelial function are, at least in part, reversible in patients with established vascular disease, supporting further the hypothesis that homocyst(e)ine-lowering through vitamin supplementation may have vasoprotective effects.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Bradley L. Urquhart, David J. Freeman, J. David Spence, and Andrew A. House
The Journal of Clinical Pharmacology, 2007, Volume 47, Number 8, Page 991
[2]
Yajing Wang, Lianyun Wang, Xiaojie Ai, Jianli Zhao, Xiangfang Hao, Yutong Lu, and Zhongdong Qiao
International Immunopharmacology, 2004, Volume 4, Number 13, Page 1675
[3]
A Hakki, H Friedman, and S Pross
International Immunopharmacology, 2002, Volume 2, Number 10, Page 1403
[4]
Bradley L. Urquhart, David J. Freeman, J. David Spence, and Andrew A. House
American Journal of Kidney Diseases, 2007, Volume 49, Number 1, Page 109
[5]
Martin Weger, Olaf Stanger, Hannes Deutschmann, Franz Josef Leitner, Wilfried Renner, Otto Schmut, Jürgen Semmelrock, and Anton Haas
American Journal of Ophthalmology, 2002, Volume 134, Number 1, Page 57
[6]
Radjesh J. Bisoendial, G. Kees Hovingh, Eric de Groot, John J.P. Kastelein, Peter J. Lansberg, and Erik S.G. Stroes
Current Opinion in Lipidology, 2002, Volume 13, Number 6, Page 595
[7]
Stefano Zoccolella, Caterina Bendotti, Ettore Beghi, and Giancarlo Logroscino
Amyotrophic Lateral Sclerosis, 2010, Volume 11, Number 1-2, Page 140
[8]
Wolfgang Herrmann, Ulrich Hübner, Ines Koch, Rima Obeid, Ulrich Retzke, and Jürgen Geisel
Clinical Chemistry and Laboratory Medicine, 2004, Volume 42, Number 10
[9]
Jens Weingaertner, Jochen Fanghaenel, Volker Bienengraeber, and Karsten K.H. Gundlach
Journal of Cranio-Maxillofacial Surgery, 2005, Volume 33, Number 5, Page 297
[10]
Nieves Díez, Raquel Pérez, Verónica Hurtado, and Santiago Santidrián
British Journal of Nutrition, 2005, Volume 94, Number 02, Page 204
[11]
Barbara Giambene, Andrea Sodi, Francesco Sofi, Rossella Marcucci, Sandra Fedi, Rosanna Abbate, Domenico Prisco, and Ugo Menchini
Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, Volume 247, Number 5, Page 693
[12]
M. Kuntay Kokanalı, Demet Öztürkkan, Naim Ünsal, Perran Möroy, Tayfun Güngör, and Leyla Mollamahmutoğlu
Archives of Gynecology and Obstetrics, 2008, Volume 278, Number 6, Page 531
[13]
Gunhal Kamburoglu, Koray Gumus, Sibel Kadayıfcılar, and Bora Eldem
Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, Volume 244, Number 5, Page 565
[14]
B Akoglu, M Schrott, H Bolouri, A Jaffari, E Kutschera, W F Caspary, and D Faust
European Journal of Clinical Nutrition, 2008, Volume 62, Number 6, Page 796
[15]
B Akoglu, P Kindl, N Weber, J Trojan, W F Caspary, and D Faust
European Journal of Clinical Nutrition, 2008, Volume 62, Number 3, Page 430
[16]

Comments (0)

Please log in or register to comment.